Genetics of rheumatoid arthritis: Is there a scientific explanation for the human leukocyte antigen association?

Current Opinion in Rheumatology

Volumn 14, Issue 3, 2002, Pages 254-259

  Buckner, Jane H ^a   Nepom, Gerald T ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETICS; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ALLELES; ARTHRITIS, RHEUMATOID; HLA ANTIGENS; HLA-DR4 ANTIGEN; HUMANS;

EID: 0036225867     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200205000-00011     Document Type: Review

References (44)

1. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis
2. Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis
3. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
4. The molecular basis for HLA class II associations with rheumatoid arthritis
5. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
6. Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis
7. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis
8. Genetic anticipation in rheumatoid arthritis in Europe
9. Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families
10. Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition
11. Influence of HLA-DR alleles on rheumatoid arthritis: Susceptibility and severity in Argentine patients
12. Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis
13. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis
14. Immunogenetic markers and seropositivity predict radiologic progression in early rheumatoid arthritis independent of disease activity
15. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years
16. HLA-DRB1 typing in rheumatoid arthritis: Predicting response to specific treatments
17. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases
18. Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups
19. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
20. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease
21. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis
22. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis
23. Tumor necrosis factor microsateltites and HLA-DRB1 *, HLA-DQA1 *, and HLA-DOB1 * alleles in Peruvian patients with rheumatoid arthritis
24. Tumor necrosis factor 5′ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families
25. Tumor necrosis factor markers show sex-influenced association with rheumatoid arthritis
26. Primary association of a MICA allele with protection against rheumatoid arthritis
27. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci
28. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region
29. Identification of type II collagen (261-273) specific T cell clones in a patient with relapsing polychondritis
30. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen
31. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions
32. The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism
33. Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells
34. HLA-DRB1 gene transcripts in rheumatoid arthritis
35. Specific overexpression of rheumatoid arthritis-associated HLA-DR alleles and presentation of low-affinity peptides
36. Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis
37. HLA class II association with rheumatoid arthritis: Facts and interpretations
38. Autoimmunity versus tolerance: Analysis using transgenic mice
39. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis
40. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs
41. The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule
42. High concentration of soluble HLA-DR in the synovial fluid: Generation and significance in 'rheumatoid-like' inflammatory joint diseases
43. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes
44. T cell selection and differential activation on structurally related HLA-DR4 ligands